TITLE

OPN and αvβ3 Expression are Predictors of Disease Severity and Worse Prognosis in Hepatocellular Carcinoma

AUTHOR(S)
Jin, Yi; Chen, Jian-ning; Feng, Zhi-ying; Zhang, Zhi-gang; Fan, Wen-zhe; Wang, Yu; Li, Jia-ping
PUB. DATE
February 2014
SOURCE
PLoS ONE;Feb2014, Vol. 9 Issue 2, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Expressions of OPN and αvβ3 are associated with a poor prognosis in many malignancies. However, their relationship in hepatocellular carcinoma remains unclear. We systematically collected hepatocellular carcinoma tissue samples from 305 patients over 3 years, and analyzed the status of OPN and αvβ3 in hepatocellular carcinoma and correlate expression with patient disease status and survival outcome. Our study results indicated that OPN and αvβ3 are expressed at significantly higher rates in hepatocellular carcinoma compared with adjacent non-tumorous tissue (69.5% vs 18.4%, p<0.01 and 77.4% vs 21.6%, p<0.01, respectively). Both OPN and αvβ3 expression levels are associated with poor prognostic factors, including tumor size, capsular invasion, tumor thrombus of the portal vein, metastasis of the lymph node and clinical staging. Patients expressing OPN and αvβ3 had significantly shorter survival compared with patients negative for protein expression (p<0.01). Multivariate analysis also showed that both OPN and αvβ3 expression are independent prognostic factors for poorer survival in hepatocellular carcinoma. By this study, we conclude that OPN and αvβ3 are negative prognostic predictors in patients with hepatocellular carcinoma. The expressions of both OPN and αvβ3 are associated with worse survival outcome.
ACCESSION #
94729701

 

Related Articles

  • The Singapore Liver Cancer Recurrence (SLICER) Score for Relapse Prediction in Patients with Surgically Resected Hepatocellular Carcinoma. Ang, Soo Fan; Ng, Elizabeth Shu-Hui; Li, Huihua; Ong, Yu-Han; Choo, Su Pin; Ngeow, Joanne; Toh, Han Chong; Lim, Kiat Hon; Yap, Hao Yun; Tan, Chee Kiat; Ooi, London Lucien Peng Jin; Chung, Alexander Yaw Fui; Chow, Pierce Kah Hoe; Foo, Kian Fong; Tan, Min-Han; Cheow, Peng Chung // PLoS ONE;Apr2015, Vol. 10 Issue 4, p1 

    Background and Aims: Surgery is the primary curative option in patients with hepatocellular carcinoma (HCC). Current prognostic models for HCC are developed on datasets of primarily patients with advanced cancer, and may be less relevant to resectable HCC. We developed a postoperative nomogram,...

  • Assessing the feasibility of clinicopathological features of hepatic resection for hepatocellular carcinoma in patients over 80 years of age. HIROYA IIDA; MASAKI KAIBORI; KOSUKE MATSUI; MORIHIKO ISHIZAKI; MASANORI KON // Molecular & Clinical Oncology;2017, Vol. 6 Issue 1, p29 

    The aim of the present study was to evaluate the clinicopathological features, benefits and problems associated with hepatic resection of hepatocellular carcinoma in patients aged ≥80 years. Between 2006 and 2013, hepatic resection was performed in 395 hepatocellular carcinoma patients,...

  • Low CADM2 expression predicts high recurrence risk of hepatocellular carcinoma patients after hepatectomy. Yang, Sen; Yan, Hong-Li; Tao, Qi-Fei; Yuan, Sheng-Xian; Tang, Guan-Nan; Yang, Yuan; Wang, Li-Li; Zhang, Yi-Liang; Sun, Shu-Han; Zhou, Wei-Ping // Journal of Cancer Research & Clinical Oncology;Jan2014, Vol. 140 Issue 1, p109 

    Purpose: To investigate the expression and clinical significance of CADM2 in hepatocellular carcinomas (HCC). Methods: The level of expression of CADM2 mRNA was assessed in frozen tumor specimens and adjacent noncancerous tissues from 30 HCC patients by real-time PCR. The protein level was...

  • High expression of IL-17 and IL-17RE associate with poor prognosis of hepatocellular carcinoma. Rui Liao; Jian Sun; Han Wu; Yong Yi; Wang, Jia-Xing; He, Hong-Wei; Cai, Xiao-Yan; Zhou, Jian; Cheng, Yun-Feng; Fan, Jia; Qiu, Shuang-Jian // Journal of Experimental & Clinical Cancer Research (17569966);2013, Vol. 32 Issue 1, p1 

    Background: Hepatocellular carcinoma (HCC) is a typical malignancy in a background of chronic inflammation. Th17 cells (a major source of IL-17) constitute crucial components of infiltrating inflammatory/immune cells in HCC and can amplify inflammatory response via binding to interleukin-17...

  • Expression and prognostic value of Ars2 in hepatocellular carcinoma. He, Qian; Huang, Yongde; Cai, Lei; Zhang, Shaobo; Zhang, Chenghua // International Journal of Clinical Oncology;Oct2014, Vol. 19 Issue 5, p880 

    Background: Hepatocellular carcinoma (HCC) is one of the most common malignant tumors in China. Arsenic resistance protein 2 (Asr2) was reported to be important for microRNA (miR) biogenesis, and its depletion could reduce the levels of several miRs, including miR-21, which is over-expressed in...

  • Decreased Expression of TMEM173 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma. Bu, Yang; Liu, Fang; Jia, Qing-An; Yu, Song-Ning // PLoS ONE;11/4/2016, Vol. 11 Issue 11, p1 

    Hepatocellular carcinoma (HCC) is one of the most lethal cancer types, and chronic infection with Hepatitis B Virus (HBV) is identified as the strongest risk factor for HCC. Transmembrane Protein 173 (TMEM173) is a pattern recognition receptor which functions as a major regulator of the innate...

  • TIMP-3 Expression Associates with Malignant Behaviors and Predicts Favorable Survival in HCC. Gu, Xuefeng; Fu, Maoying; Ding, Yuqin; Ni, Huihui; Zhang, Wei; Zhu, Yanfang; Tang, Xiaojun; Xiong, Lin; Li, Jiang; Qiu, Liang; Xu, Jiaren; Zhu, Jin // PLoS ONE;Aug2014, Vol. 9 Issue 8, p1 

    The tissue inhibitors of metalloproteinases (TIMPs) are proteins that specifically inhibit the proteolytic activity of the matrix metalloproteinases (MMPs). TIMP-3, the only member of the TIMPs that can tightly bind to the extracellular matrix, has been identified as a unique tumor suppressor...

  • A Seven-microRNA Expression Signature Predicts Survival in Hepatocellular Carcinoma. Zhang, Jian; Chong, Charing C. N.; Chen, George G.; Lai, Paul B. S. // PLoS ONE;Jun2015, Vol. 10 Issue 6, p1 

    Hepatocellular carcinoma (HCC) is the fifth common cancer. The differential expression of microRNAs (miRNAs) has been associated with the prognosis of various cancers. However, limited information is available regarding genome-wide miRNA expression profiles in HCC to generate a tumor-specific...

  • Stem cell factor is a novel independent prognostic biomarker for hepatocellular carcinoma after curative resection. Wang, Xiuchao; Ren, He; Zhao, Tiansuo; Chen, Jing; Sun, Wei; Sun, Yan; Ma, Weidong; Wang, Jian; Gao, Chuntao; Gao, Song; Lang, Mingxiao; Jia, Li; Hao, Jihui // Carcinogenesis;Oct2014, Vol. 35 Issue 10, p2283 

    We have independently validated SCF and CD34 as prognostic biomarkers for HCC, and report for the first time that SCF is a novel independent prognostic biomarker for patients with HCC after curative resection. Combining SCF and CD34 further improves prognostic stratification.Stem cell factor...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics